ABS and Nagoya Protocol
From GGBN Wiki
Contents
- 1 Access and Benefit Sharing
- 1.1 GGBN Guidance on Access and Benefit Sharing
- 1.2 GGBN Example Material Transfer Agreements
- 1.3 GGBN Access and Benefit Sharing Fact Sheet and Answers to Frequently Asked Questions
- 1.4 Other Resources for Access and Benefit Sharing
- 1.5 GGBN's views on Digital Sequence Information on Genetic Resources
Access and Benefit Sharing
GGBN Guidance on Access and Benefit Sharing
- Best Practice for Access and Benefit-Sharing
- Code of Conduct
- ABS Survey Results
- ABS Fact Sheet and Answers to Frequently Asked Questions
GGBN Example Material Transfer Agreements
GGBN Access and Benefit Sharing Fact Sheet and Answers to Frequently Asked Questions
Other Resources for Access and Benefit Sharing
- Barker K 2017, Supporting GGBN Member Compliance on ABS
- Da Silva M, 2018, ABS Brazilian Legislation
- Löhne C, 2016, Access and Benefit Sharing, Introduction to the Concept, its Implementation and Relevance to Genomic Collections and Researchers in Europe
- Davis K, Holanda P, Lyal C, Da Silva M and Fontes E, 2016, Implementation of Nagoya Protocol Dialogue between Brazil and the EU
- Barker K, Davis K, Da Silva M, Desmeth P, Droege G, Fulcher T, Seberg O, Zimkus B, 2018, GGBN Conference ABS workshop Report: Tracking Information on Use of Genetic Samples
- Rohden F, et al. 2020, Combined study on digital sequence information in public and private databases and traceability
